Showing 171-180 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Employing PD-L1-Modified Biomaterials to Induce Islet Allograft Tolerance Following Perihepatic Transplantation in Nonhuman Primates | Regents of the University of Minnesota | Melanie Graham | Cures | 01-April-2025 to 31-March-2027 | $918,744.88 |
| Determining how frequent infections alter autoreactive T-cell fates and type 1 diabetes risk | Regents of the University of Minnesota | Zachary Shaheen | Cures | 01-June-2024 to 31-May-2025 | $199,890.00 |
| Effects of Volagidemab on Glucagon Rescue from Insulin-Induced Hypoglycemia | REMD Biotherapeutics | Dung Thai | Improving Lives | 30-June-2023 to 29-June-2026 | $672,000.00 |
| JDRF Cures Patient Preference Study in Type 1 Diabetes | RTI International | Carol Mansfield | Transportfolio | 01-July-2023 to 23-August-2025 | $756,300.00 |
| Using Genome Sequencing and Genetic Risk Scores to Identify Newborns with Serious Health Conditions: A Statewide Implementation Study | RTI International | Curt Scharfe | Cures | 01-December-2022 to 30-November-2025 | $3,356,049.93 |
| The master regulator transcription factor, Zbtb20, defines and controls a regulatory T cell subset that controls tissue inflammation. | Rutgers Biomedical and Health Sciences | Derek Sant’Angelo | Cures | 01-March-2023 to 28-February-2026 | $935,026.00 |
| Treating Type 1 Diabetes: Role of Kisspeptin | Rutgers Biomedical and Health Sciences | Moshmi Bhattacharya | Cures | 01-April-2024 to 31-March-2026 | $140,000.00 |
| PREdictors for DiabetIC Ketoacidosis at Diagnosis of Type 1 Diabetes (The PREDICT study) | Rutgers, The State University of New Jersey | Chintan Dave | Cures | 01-August-2022 to 31-July-2025 | $695,404.04 |
| Inflammatory cytokines rewire the proinsulin interaction network in human islets | Sanford-Burnham Medical Research Institute | Pamela Itkin-Ansari | Cures | 01-May-2022 to 30-April-2025 | $987,642.98 |
| Achieving Health in Emerging Adults with Diabetes Program | Seattle Childrens Hospital | Faisal Malik | Improving Lives | 01-September-2024 to 31-August-2028 | $1,734,029.00 |